NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Qubit Pharmaceuticals

Qubit Pharmaceuticals

Private
ParisHealthcare & Life Scienceshttps://www.qubit-pharmaceuticals.com/

Last Round

Grant

Jul 10, 2024

Total Funding Raised

$41.91M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Qubit Pharmaceuticals is a biotechnology company that develops a drug discovery platform using quantum physics, AI, and high-performance computing to create novel treatments for oncology and inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Infrastructure

Keywords

drug discoverytechbiomolecular simulationdrug discovery platformcomputational drug discoverypreclinical developmentsmall-molecule drugin silico drug designai drug discoverylead optimizationbinding affinity predictionquantum emulationdigital twinhpchigh-performance computing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Qubit Pharmaceuticals Comps

Public and private peers based on sector, stage, and business model.

Qubit Pharmaceuticals comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Qubit Pharmaceuticals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 10, 2024
GrantNov 16, 2023
GrantSep 26, 2023
GrantJun 16, 2022
SeedJun 10, 2022
Grant
Jun 16, 2021

Key People

Founding team and executive leadership

Robert Marino

CEO

Executive Team

Robin Chaudret

Chief Technology Officer

Executive Team

Marion Pierfitte

Chief Operating Officer

Executive Team

Romain Delassus

CIO CPO

Executive Team

Qubit Pharmaceuticals Investors

Notable investors and investment history

Qubit Pharmaceuticals investors
InvestorRounds
European Innovation Council FundGrant
Wellcome LeapGrant
BpifranceGrant
Secrétariat Général pour l'InvestissementGrant
QuantonationSeed, Pre Seed
Omnes CapitalSeed
XAngeSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Oct 1, 2025

    Grew to 7 programs in oncology, immunology, and antivirals.

  • Sep 2, 2025

    Launched the world's most powerful AI foundation model for molecular simulation.

Qubit Pharmaceuticals Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Qubit Pharmaceuticals Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Qubit Pharmaceuticals's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range67
Year Founded2020
Last FundingJul 10, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.